Glide Pharma raises £2.7 million to advance drug delivery product

Wednesday 10 February 2010

Glide Pharmaceutical Technologies Ltd has raised £2.7 million in a new investment round bringing total funds raised for its needle-free delivery technology up to £10 million. The funds will be used to take its second drug product into the clinic.

Full text available to subscribers only. Click here for information on subscribing to MedNous.